首页> 外文期刊>The Journal of Supercritical Fluids >Experimental measurement and correlation for solubility of piroxicam (a non-steroidal anti-inflammatory drugs (NSAIDs)) in supercritical carbon dioxide
【24h】

Experimental measurement and correlation for solubility of piroxicam (a non-steroidal anti-inflammatory drugs (NSAIDs)) in supercritical carbon dioxide

机译:吡罗昔康(一种非甾体类抗炎药(NSAIDs))在超临界二氧化碳中的溶解度的实验测量和相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Since the knowledge of pharmaceutical solubilities in the supercritical carbon dioxide is one of the first essential necessities for designing the supercritical carbon dioxide-based processes, solubility of piroxicam a non-steroidal anti-inflammatory drug was experimentally measured. In this regard, a static method coupled with gravimetric method was used to measure the solubility of piroxicam in the supercritical carbon dioxide in temperature and pressure range of 308.15-338.15 K and 16-40 MPa, respectively. The obtained solubility data were in the range of 1.17 × 10~(-5) and 5.12 × 10~(-4) based on the mole fraction (mole piroxicam/(mole piroxicam+mole CO2)) then modeled using four different density based correlations namely Bartle et al., Mendez-Santiago-Teja, Chrastil and Kumar and Johnston models. The results of error analysis revealed that the used correlations were potential to correlate the solubility of piroxicam with minimum and maximum average absolute relative deviation percents (AARD%) of 14.4% and 15.2%, respectively.
机译:由于对药物在超临界二氧化碳中的溶解度的了解是设计基于超临界二氧化碳的工艺的首要必要条件之一,因此对吡罗昔康(一种非甾体类抗炎药)的溶解度进行了实验测量。在这方面,采用静态方法与重量分析法相结合,分别测定吡罗昔康在308.15-338.15 K和16-40 MPa温度和压力范围内在超临界二氧化碳中的溶解度。基于摩尔分数(摩尔吡罗昔康/(摩尔吡罗昔康+摩尔CO2))获得的溶解度数据在1.17×10〜(-5)和5.12×10〜(-4)范围内,然后使用四种不同的密度模型相关性包括Bartle等人,Mendez-Santiago-Teja,Chrastil和Kumar和Johnston模型。误差分析的结果表明,所使用的相关性有可能使吡罗昔康的溶解度与最小和最大平均绝对相对偏差百分比(AARD%)分别为14.4%和15.2%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号